Paradigm Biocapital Advisors LP - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 80 filers reported holding OYSTER PT PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q3 2022$9,264,000
+60.5%
1,648,316
+23.6%
1.24%
+7.3%
Q2 2022$5,773,000
-49.8%
1,333,330
+35.0%
1.15%
-62.1%
Q1 2022$11,497,000
+107.0%
987,698
+224.6%
3.04%
+91.7%
Q4 2021$5,555,000304,2381.59%
Other shareholders
OYSTER PT PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$50,554,00015.36%
KPCB XIV Associates, LLC 367,987$6,719,0004.17%
NEA Management Company, LLC 5,925,287$108,196,0002.19%
Paradigm Biocapital Advisors LP 304,238$5,555,0001.59%
Sio Capital Management, LLC 181,857$3,321,0001.00%
COWEN AND COMPANY, LLC 509,794$9,309,0000.84%
RTW INVESTMENTS, LP 2,058,504$37,588,0000.55%
ACT CAPITAL MANAGEMENT, LLC 13,500$247,0000.18%
COOPER CREEK PARTNERS MANAGEMENT LLC 79,510$1,452,0000.17%
Point72 Asset Management, L.P. 2,101,441$38,372,0000.15%
View complete list of OYSTER PT PHARMA INC shareholders